Quantum-Si (QSI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Voting matters and shareholder proposals
Shareholders will vote to elect ten directors for one-year terms expiring in 2027.
Proposal to ratify PricewaterhouseCoopers LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation for named executive officers is included.
Board recommends voting in favor of all proposals and nominees.
Other business may be addressed if properly brought before the meeting.
Board of directors and corporate governance
Ten director nominees are listed, each recommended for election to serve until 2027.
Executive compensation and say-on-pay
Advisory, non-binding vote on executive compensation for named executive officers is on the agenda.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Quantum-Si
- Director elections, auditor ratification, and executive pay are up for vote at a virtual annual meeting.QSI
Proxy filing1 Apr 2026 - 2026 emphasizes consumables growth and Proteus launch, with strong cash reserves and cost control.QSI
Q4 20253 Mar 2026 - Q2 2024 revenue rose 203% to $622,000, with a 57% margin and cash runway into 2026.QSI
Q2 20242 Feb 2026 - Rapid innovation and commercial expansion position the platform for strong growth in proteomics.QSI
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Automated protein sequencing platform drives adoption and innovation across research sectors.QSI
H.C. Wainwright 26th Annual Global Investment Conference21 Jan 2026 - Q3 revenue up 252.9% to $787,000, but full-year guidance was lowered amid longer sales cycles.QSI
Q3 202414 Jan 2026 - Proteus and Platinum Pro launch drive scalable, automated, and versatile proteomics workflows.QSI
Investor Day 202413 Jan 2026 - Q4 revenue up 52% sequentially, 183% YoY, $86M raised, and cash runway into 2027.QSI
Q4 202424 Dec 2025 - Up to $300M in securities may be offered, with $100M via at-the-market sales through Leerink Partners.QSI
Registration Filing16 Dec 2025